找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of the Breast and Axilla in the Neoadjuvant Setting; Atilla Soran,Faina Nakhlis Book 2022 The Editor(s) (if applicable) and The

[復(fù)制鏈接]
樓主: Mottled
31#
發(fā)表于 2025-3-26 23:56:55 | 只看該作者
32#
發(fā)表于 2025-3-27 01:50:12 | 只看該作者
33#
發(fā)表于 2025-3-27 08:56:37 | 只看該作者
conomic decision making. Through in-depth analyses of concepts, data, methods, and policies, this book stimulates future studieson global pandemics and their impacts on society at different levels..978-3-030-72810-6978-3-030-72808-3Series ISSN 2523-7780 Series E-ISSN 2523-7799
34#
發(fā)表于 2025-3-27 10:16:46 | 只看該作者
35#
發(fā)表于 2025-3-27 14:41:37 | 只看該作者
Breast Cancer Imaging Pre- and Post-Neoadjuvant Systemic Therapying technology expands to include new techniques, there is a new level of understanding the advantages and efficacy of imaging when evaluating and monitoring tumor response. Imaging indications, protocols, techniques, and modalities will be reviewed.
36#
發(fā)表于 2025-3-27 20:57:39 | 只看該作者
The Macroscopic and Microscopic Evaluation of Breast and Axillary Lymph Node Specimens Following Neo will also permit more meaningful and reliable comparisons across ongoing and future clinical trials. This chapter discusses the primary issues and common challenges encountered in the macroscopic and microscopic evaluation of breast and axillary lymph node specimens following NAST.
37#
發(fā)表于 2025-3-27 23:18:38 | 只看該作者
38#
發(fā)表于 2025-3-28 02:48:34 | 只看該作者
Book 2022atients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medica
39#
發(fā)表于 2025-3-28 08:30:42 | 只看該作者
Neoadjuvant Therapy for Breast Canceriated with long-term prognosis, and a pathological complete response to systemic therapy is associated with an extremely favorable disease-free and overall survival. Neoadjuvant systemic therapy should be offered to appropriate surgical candidates based on the clinical parameters of newly diagnosed invasive breast cancer.
40#
發(fā)表于 2025-3-28 10:52:57 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 07:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
阿拉善盟| 德惠市| 泉州市| 九寨沟县| 大洼县| 鄂温| 平乡县| 巴中市| 望奎县| 清水县| 清河县| 曲松县| 涿鹿县| 通化县| 龙里县| 辛集市| 抚松县| 达日县| 广西| 达孜县| 大荔县| 昌都县| 汕头市| 扶风县| 周宁县| 山西省| 巴里| 松原市| 兰州市| 亳州市| 香河县| 保山市| 东乌珠穆沁旗| 喜德县| 灵寿县| 凉城县| 柘城县| 绥江县| 定结县| 沙田区| 翼城县|